BIOMERIEUX

Lobbying for BIOMERIEUX · Medical diagnostics

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$190,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Utah

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 4

Tariff (miscellaneous tariff bills)

Discussions regarding tariff proposals

Budget/Appropriations

Discussions regarding Veterans Affairs Appropriations Discussions regarding Indian Health Services Appropriations

Health Issues

Issues regarding womens health Equitable Community Access to Pharmacists Services Act

Medical/Disease Research/Clinical Labs

Discussions regarding PASTEUR Act, the RESULTS Act, CLIA Modernization, and antimicrobial resistance.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.